{"id":1223,"date":"2023-04-19T11:26:18","date_gmt":"2023-04-19T11:26:18","guid":{"rendered":"https:\/\/www.arcgroup.io\/oxford\/?p=1223"},"modified":"2023-04-19T11:27:06","modified_gmt":"2023-04-19T11:27:06","slug":"omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth","status":"publish","type":"post","link":"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/","title":{"rendered":"OMass Therapeutics makes move to ARC Oxford as it announces new phase of growth"},"content":{"rendered":"\n<!-- Back button -->\n<div class=\"back-button-block__container\">\n\t<a href=\"https:\/\/www.arcgroup.io\/oxford\/community\/\" class=\"back-button-block\">\n\t\t<svg class=\"back-button-block__arrow\" width=\"13\" height=\"13\">\n\t\t\t<use xlink:href=\"#small-arrow\"><\/use>\n\t\t<\/svg>\n\t\tBack to Community\t<\/a>\n<\/div>\n\n\n\n<section class=\"feature-banner\" id=\"block_52a52247e5f4ef972671e79add489fdd\"> \n    <div class=\"feature-banner__container\">\n            <picture class=\"\">\n        <source srcset=\"https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2023\/04\/Omass-scaled.jpg 2560w, https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2023\/04\/Omass-300x200.jpg 300w, https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2023\/04\/Omass-1024x684.jpg 1024w, https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2023\/04\/Omass-768x513.jpg 768w, https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2023\/04\/Omass-1000x668.jpg 1000w\" type=\"image\/jpeg\" sizes=\"(max-width: 768px) 768px, (max-width: 1024px) 1024px, 100vw\">\n        <img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2023\/04\/Omass-scaled.jpg\" \/>\n            <\/picture>\n\n    <\/div>\n<\/section>\n\n\n<h2 class=\"wp-block-post-title\">OMass Therapeutics makes move to ARC Oxford as it announces new phase of growth<\/h2>\n\n\n    <ul class=\"ed-post-categories\">\n                    <li class=\"arc-orange\">\n                <a href=\"https:\/\/www.arcgroup.io\/oxford\/blog\/category\/news\/\">News<\/a>\n            <\/li>\n                    <li class=\"arc-purple\">\n                <a href=\"https:\/\/www.arcgroup.io\/oxford\/blog\/category\/corporate\/\">Corporate<\/a>\n            <\/li>\n            <\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Move to new purpose-built 16,000ft<sup>2<\/sup> flagship site on ARC Oxford campus to support continued company growth<\/li>\n\n\n\n<li>Expansion of senior leadership team with the appointment of Winfried Barchet Ph.D. as Vice President of Immunology<\/li>\n<\/ul>\n\n\n\n<p>OMass Therapeutics, a biotechnology company that identifies medicines against highly validated target ecosystems, today announces the next phase of its growth towards becoming a fully integrated biopharmaceutical company. This includes a move to purpose-designed R&amp;D and office facilities at ARC Oxford, and expansion of its senior leadership team with the appointment of Winfried Barchet Ph.D. as its Vice President of Immunology.<\/p>\n\n\n\n<p>OMass has expanded over the past 12 months, with a total headcount of 55 employees.&nbsp; The new flagship site offers 16,000ft<sup>2<\/sup> of mixed-use space and will enable co-location and enhanced collaboration of discovery research teams from OMass\u2019 former sites in Oxford and Nottingham.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p><strong>David Williams, Director of Leasing at ARC said: <\/strong>\u201cWe\u2019re delighted to be supporting OMass Therapeutics on its growth journey. It\u2019s a leading UK biopharma company at the forefront of innovation in drug discovery. The new building keeps it at the heart of a vibrant ecosystem of innovative companies in Oxford and offers access to communal, social and co-working spaces and a curated programme of events for campus members.\u201d<\/p>\n<\/blockquote>\n\n\n\n<p>ARC has fully refurbished the laboratory space to meet OMass\u2019 scientific and technical requirements, including, air handling for mass spectrometry and cell culture, and new facilities for chemistry and structural biology to support ongoing and future drug discovery efforts. Office space has also been designed to better enable collaborative working both on-site and virtually.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p><strong>Dan Williams, Director of Asset Management at ARC Oxford<\/strong>, said: &#8220;We\u2019re delighted that our community of life science organisations is expanding at ARC Oxford. This is testament to Oxfordshire\u2019s thriving science and tech ecosystem, and we\u2019re pleased that our investment into the campus is creating state-of-the-art, fitted laboratory space that fosters innovation and allows our members to continue their growth journey in today&#8217;s global economy.\u201d<\/p>\n<\/blockquote>\n\n\n\n<p>The Company also continues to expand its senior leadership team and enhance depth of immunology expertise with the recent appointment of Winfried Barchet Ph.D. as its Vice President of Immunology. Winfried brings more than 15 years of project and team leadership experience spanning discovery, translational research and drug discovery in both academia and industry. He joins from IFM Therapeutics where he was the Executive Director of Innate Immunity focusing on drugging targets in the inflammasome and the nucleic acid sensing pathways. Prior to that, he worked at Roche as a discovery area leader in innate immunity and in academia at the University of Bonn where he was the Professor of Translational Immunology at the German Centre for Infection Research.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p><strong>Ros Deegan, CEO of OMass said: <\/strong>\u201cIt is an exciting period of growth for OMass Therapeutics as we move to our new premises, bringing all our staff under one roof, and welcome Winfried to the senior leadership team. Winfried brings a wealth of expertise in immunology as we continue to execute on our plans to discover drugs for previously undruggable targets, and ultimately, bring life changing medicines to patients.\u201d<\/p>\n<\/blockquote>\n\n\n    <section class=\"news-archive \" id=\"block_d6e4f752995446b67aa89ca36b9e1347\">\n                    <div class=\"ed-container news-archive__title ed-archive-header__title ed-archive-header__title--large\">\n                <div class=\"ed-row\">\n                    <div class=\"ed-col ed-col__half\">\n                        \n                            <h3>More News<\/h3>\n                                            <\/div>\n                    <div class=\"ed-col ed-col__half\">\n                                                    <a href=\"https:\/\/www.arcgroup.io\/oxford\/community\/\" target=\"\">\n                                View all news &rarr;\n                            <\/a>\n                                            <\/div>\n                <\/div>\n            <\/div>\n                <div class=\"ed-container\">\n            <div class=\"ed-row\">\n                \n<article class=\"news-block ed-col ed-col__third\">\n\t<div class=\"news-block__inner\">\n\t\t<!-- Thumbnail -->\n\t\t<figure class=\"wp-block-post-featured-image\">\n\t\t\t<a href=\"https:\/\/www.arcgroup.io\/oxford\/blog\/2026\/03\/24\/accession-therapeutics-awarded\/\">\n\t\t\t\t    <picture class=\"\">\n        <source srcset=\"https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2024\/05\/accession1.png 1200w, https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2024\/05\/accession1-300x169.png 300w, https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2024\/05\/accession1-1024x576.png 1024w, https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2024\/05\/accession1-768x432.png 768w, https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2024\/05\/accession1-1000x563.png 1000w, https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2024\/05\/accession1-475x267.png 475w\" type=\"image\/png\" sizes=\"(min-width: 1200px) 34vw, (min-width: 768px) 50vw, 100vw\">\n        <img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2024\/05\/accession1.png\" \/>\n            <\/picture>\n\n\n\t\t\t\t<!-- Terms -->\n\t\t\t\t\t\t\t\t\t<div class=\"news-block__categories\">\n\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"arc-orange\">News<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/a>\n\t\t<\/figure>\n\n\t\t<!-- Title -->\n\t\t<div class=\"news-block__inner-title\">\n\t\t\t<a href=\"https:\/\/www.arcgroup.io\/oxford\/blog\/2026\/03\/24\/accession-therapeutics-awarded\/\" target=\"_self\">\n\t\t\t\tAccession Therapeutics awarded \u20ac7.5m Horizon Europe grant funding to advance TROCEPT-01 (ATTR-01), a first-in-class, tumour-activated immunotherapy\t\t\t<\/a>\n\t\t<\/div>\n\t<\/div>\n<\/article>\n\n<article class=\"news-block ed-col ed-col__third\">\n\t<div class=\"news-block__inner\">\n\t\t<!-- Thumbnail -->\n\t\t<figure class=\"wp-block-post-featured-image\">\n\t\t\t<a href=\"https:\/\/www.arcgroup.io\/oxford\/blog\/2026\/03\/12\/childbase-partnership-announces-nursery-opening-at-arc-oxford\/\">\n\t\t\t\t    <picture class=\"\">\n        <source srcset=\"https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2026\/03\/Garsington-Road-image.jpg 1110w, https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2026\/03\/Garsington-Road-image-300x201.jpg 300w, https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2026\/03\/Garsington-Road-image-1024x685.jpg 1024w, https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2026\/03\/Garsington-Road-image-768x513.jpg 768w, https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2026\/03\/Garsington-Road-image-1000x668.jpg 1000w\" type=\"image\/jpeg\" sizes=\"(min-width: 1200px) 34vw, (min-width: 768px) 50vw, 100vw\">\n        <img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2026\/03\/Garsington-Road-image.jpg\" \/>\n            <\/picture>\n\n\n\t\t\t\t<!-- Terms -->\n\t\t\t\t\t\t\t\t\t<div class=\"news-block__categories\">\n\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"arc-orange\">News<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/a>\n\t\t<\/figure>\n\n\t\t<!-- Title -->\n\t\t<div class=\"news-block__inner-title\">\n\t\t\t<a href=\"https:\/\/www.arcgroup.io\/oxford\/blog\/2026\/03\/12\/childbase-partnership-announces-nursery-opening-at-arc-oxford\/\" target=\"_self\">\n\t\t\t\tChildbase Partnership announces new Garsington Road day nursery opening at ARC Oxford\t\t\t<\/a>\n\t\t<\/div>\n\t<\/div>\n<\/article>\n\n<article class=\"news-block ed-col ed-col__third\">\n\t<div class=\"news-block__inner\">\n\t\t<!-- Thumbnail -->\n\t\t<figure class=\"wp-block-post-featured-image\">\n\t\t\t<a href=\"https:\/\/www.arcgroup.io\/oxford\/blog\/2026\/03\/10\/oxa-raises-103m\/\">\n\t\t\t\t    <picture class=\"\">\n        <source srcset=\"https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2026\/03\/7df25fe8-e6ff-4960-8f12-8dae8f53943b.jpg 2402w, https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2026\/03\/7df25fe8-e6ff-4960-8f12-8dae8f53943b-300x200.jpg 300w, https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2026\/03\/7df25fe8-e6ff-4960-8f12-8dae8f53943b-1024x682.jpg 1024w, https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2026\/03\/7df25fe8-e6ff-4960-8f12-8dae8f53943b-768x512.jpg 768w, https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2026\/03\/7df25fe8-e6ff-4960-8f12-8dae8f53943b-1000x666.jpg 1000w\" type=\"image\/jpeg\" sizes=\"(min-width: 1200px) 34vw, (min-width: 768px) 50vw, 100vw\">\n        <img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2026\/03\/7df25fe8-e6ff-4960-8f12-8dae8f53943b.jpg\" \/>\n            <\/picture>\n\n\n\t\t\t\t<!-- Terms -->\n\t\t\t\t\t\t\t\t\t<div class=\"news-block__categories\">\n\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"arc-orange\">News<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/a>\n\t\t<\/figure>\n\n\t\t<!-- Title -->\n\t\t<div class=\"news-block__inner-title\">\n\t\t\t<a href=\"https:\/\/www.arcgroup.io\/oxford\/blog\/2026\/03\/10\/oxa-raises-103m\/\" target=\"_self\">\n\t\t\t\tOxa Raises $103m in Series D First Close to supercharge Industrial Mobility Automation\t\t\t<\/a>\n\t\t<\/div>\n\t<\/div>\n<\/article>\n            <\/div>\n        <\/div>\n    <\/section>\n","protected":false},"excerpt":{"rendered":"<p>OMass Therapeutics today announces the next phase of its growth towards becoming a fully integrated biopharmaceutical company. <\/p>\n","protected":false},"author":3,"featured_media":1224,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"content-type":"","inline_featured_image":false,"footnotes":""},"categories":[22,30],"tags":[4276],"class_list":["post-1223","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-corporate","tag-science-and-innovation"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>OMass Therapeutics makes move to ARC Oxford as it announces new phase of growth - ARC Oxford<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OMass Therapeutics makes move to ARC Oxford as it announces new phase of growth - ARC Oxford\" \/>\n<meta property=\"og:description\" content=\"OMass Therapeutics today announces the next phase of its growth towards becoming a fully integrated biopharmaceutical company.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/\" \/>\n<meta property=\"og:site_name\" content=\"ARC Oxford\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-19T11:26:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-04-19T11:27:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2023\/04\/Omass-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1710\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"liamjoyce\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"liamjoyce\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/\"},\"author\":{\"name\":\"liamjoyce\",\"@id\":\"https:\/\/www.arcgroup.io\/oxford\/#\/schema\/person\/58d00f0e900b593bd191db3b11c19b04\"},\"headline\":\"OMass Therapeutics makes move to ARC Oxford as it announces new phase of growth\",\"datePublished\":\"2023-04-19T11:26:18+00:00\",\"dateModified\":\"2023-04-19T11:27:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/\"},\"wordCount\":535,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.arcgroup.io\/oxford\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2023\/04\/Omass-scaled.jpg\",\"keywords\":[\"Science and innovation\"],\"articleSection\":[\"News\",\"Corporate\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/\",\"url\":\"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/\",\"name\":\"OMass Therapeutics makes move to ARC Oxford as it announces new phase of growth - ARC Oxford\",\"isPartOf\":{\"@id\":\"https:\/\/www.arcgroup.io\/oxford\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2023\/04\/Omass-scaled.jpg\",\"datePublished\":\"2023-04-19T11:26:18+00:00\",\"dateModified\":\"2023-04-19T11:27:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/#primaryimage\",\"url\":\"https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2023\/04\/Omass-scaled.jpg\",\"contentUrl\":\"https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2023\/04\/Omass-scaled.jpg\",\"width\":2560,\"height\":1710},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.arcgroup.io\/oxford\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"OMass Therapeutics makes move to ARC Oxford as it announces new phase of growth\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.arcgroup.io\/oxford\/#website\",\"url\":\"https:\/\/www.arcgroup.io\/oxford\/\",\"name\":\"ARC Oxford\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.arcgroup.io\/oxford\/#organization\"},\"alternateName\":\"ARC Oxford\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.arcgroup.io\/oxford\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.arcgroup.io\/oxford\/#organization\",\"name\":\"ARC Oxford\",\"alternateName\":\"ARC Oxford\",\"url\":\"https:\/\/www.arcgroup.io\/oxford\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.arcgroup.io\/oxford\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2025\/06\/ARC-SUBBRANDS-LOGOS-01-OXFORD-1.png\",\"contentUrl\":\"https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2025\/06\/ARC-SUBBRANDS-LOGOS-01-OXFORD-1.png\",\"width\":2084,\"height\":2084,\"caption\":\"ARC Oxford\"},\"image\":{\"@id\":\"https:\/\/www.arcgroup.io\/oxford\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.arcgroup.io\/oxford\/#\/schema\/person\/58d00f0e900b593bd191db3b11c19b04\",\"name\":\"liamjoyce\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.arcgroup.io\/oxford\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a04f7d9ac42ed6cd3a4f60afae284dec8d71c2cfb9df90888ad6368491b71999?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a04f7d9ac42ed6cd3a4f60afae284dec8d71c2cfb9df90888ad6368491b71999?s=96&d=mm&r=g\",\"caption\":\"liamjoyce\"},\"url\":\"https:\/\/www.arcgroup.io\/oxford\/blog\/author\/liamjoyce\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"OMass Therapeutics makes move to ARC Oxford as it announces new phase of growth - ARC Oxford","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/","og_locale":"en_US","og_type":"article","og_title":"OMass Therapeutics makes move to ARC Oxford as it announces new phase of growth - ARC Oxford","og_description":"OMass Therapeutics today announces the next phase of its growth towards becoming a fully integrated biopharmaceutical company.","og_url":"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/","og_site_name":"ARC Oxford","article_published_time":"2023-04-19T11:26:18+00:00","article_modified_time":"2023-04-19T11:27:06+00:00","og_image":[{"width":2560,"height":1710,"url":"https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2023\/04\/Omass-scaled.jpg","type":"image\/jpeg"}],"author":"liamjoyce","twitter_card":"summary_large_image","twitter_misc":{"Written by":"liamjoyce","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/#article","isPartOf":{"@id":"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/"},"author":{"name":"liamjoyce","@id":"https:\/\/www.arcgroup.io\/oxford\/#\/schema\/person\/58d00f0e900b593bd191db3b11c19b04"},"headline":"OMass Therapeutics makes move to ARC Oxford as it announces new phase of growth","datePublished":"2023-04-19T11:26:18+00:00","dateModified":"2023-04-19T11:27:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/"},"wordCount":535,"commentCount":0,"publisher":{"@id":"https:\/\/www.arcgroup.io\/oxford\/#organization"},"image":{"@id":"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/#primaryimage"},"thumbnailUrl":"https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2023\/04\/Omass-scaled.jpg","keywords":["Science and innovation"],"articleSection":["News","Corporate"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/","url":"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/","name":"OMass Therapeutics makes move to ARC Oxford as it announces new phase of growth - ARC Oxford","isPartOf":{"@id":"https:\/\/www.arcgroup.io\/oxford\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/#primaryimage"},"image":{"@id":"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/#primaryimage"},"thumbnailUrl":"https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2023\/04\/Omass-scaled.jpg","datePublished":"2023-04-19T11:26:18+00:00","dateModified":"2023-04-19T11:27:06+00:00","breadcrumb":{"@id":"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/#primaryimage","url":"https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2023\/04\/Omass-scaled.jpg","contentUrl":"https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2023\/04\/Omass-scaled.jpg","width":2560,"height":1710},{"@type":"BreadcrumbList","@id":"https:\/\/www.arcgroup.io\/oxford\/blog\/2023\/04\/19\/omass-therapeutics-makes-move-to-arc-oxford-as-it-announces-new-phase-of-growth\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.arcgroup.io\/oxford\/"},{"@type":"ListItem","position":2,"name":"OMass Therapeutics makes move to ARC Oxford as it announces new phase of growth"}]},{"@type":"WebSite","@id":"https:\/\/www.arcgroup.io\/oxford\/#website","url":"https:\/\/www.arcgroup.io\/oxford\/","name":"ARC Oxford","description":"","publisher":{"@id":"https:\/\/www.arcgroup.io\/oxford\/#organization"},"alternateName":"ARC Oxford","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.arcgroup.io\/oxford\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.arcgroup.io\/oxford\/#organization","name":"ARC Oxford","alternateName":"ARC Oxford","url":"https:\/\/www.arcgroup.io\/oxford\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.arcgroup.io\/oxford\/#\/schema\/logo\/image\/","url":"https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2025\/06\/ARC-SUBBRANDS-LOGOS-01-OXFORD-1.png","contentUrl":"https:\/\/www.arcgroup.io\/oxford\/wp-content\/uploads\/sites\/4\/2025\/06\/ARC-SUBBRANDS-LOGOS-01-OXFORD-1.png","width":2084,"height":2084,"caption":"ARC Oxford"},"image":{"@id":"https:\/\/www.arcgroup.io\/oxford\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.arcgroup.io\/oxford\/#\/schema\/person\/58d00f0e900b593bd191db3b11c19b04","name":"liamjoyce","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.arcgroup.io\/oxford\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/a04f7d9ac42ed6cd3a4f60afae284dec8d71c2cfb9df90888ad6368491b71999?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a04f7d9ac42ed6cd3a4f60afae284dec8d71c2cfb9df90888ad6368491b71999?s=96&d=mm&r=g","caption":"liamjoyce"},"url":"https:\/\/www.arcgroup.io\/oxford\/blog\/author\/liamjoyce\/"}]}},"_links":{"self":[{"href":"https:\/\/www.arcgroup.io\/oxford\/wp-json\/wp\/v2\/posts\/1223","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.arcgroup.io\/oxford\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.arcgroup.io\/oxford\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.arcgroup.io\/oxford\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.arcgroup.io\/oxford\/wp-json\/wp\/v2\/comments?post=1223"}],"version-history":[{"count":0,"href":"https:\/\/www.arcgroup.io\/oxford\/wp-json\/wp\/v2\/posts\/1223\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.arcgroup.io\/oxford\/wp-json\/wp\/v2\/media\/1224"}],"wp:attachment":[{"href":"https:\/\/www.arcgroup.io\/oxford\/wp-json\/wp\/v2\/media?parent=1223"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.arcgroup.io\/oxford\/wp-json\/wp\/v2\/categories?post=1223"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.arcgroup.io\/oxford\/wp-json\/wp\/v2\/tags?post=1223"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}